The Motley Fool Australia's parent company Motley . 35 . ASX:CSL . Fed Chair described as a "dangerous man" from Senator Elizabeth Warren amid scruitiny on trading conduct of FOMC . CSL (ASX: CSL) has reported its full-year results for FY20. CSL Limited (ASX:CSL) announced its quarterly earnings results on Wednesday, August, 14th. CSL Plasma is a subsidiary of CSL Behring, a global biotech leader and a member of the CSL Group of companies. All companies are highly liquid and considered "bluechip" shares. HotCopper has news, discussion, prices and market data on CSL LIMITED. BHP Group - A$ 230.9 Billion. . CSL (ASX:CSL) share price dips amid $10b acquisition rumours December 2nd, 2021 - Motley Fool CSL share price snapshot The CSL share price has climbed almost 1% in the past 12 months and almost 8% this year to date. CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. In morning trade, the biotherapeutics company's shares are down ever so slightly to $297.89. Because it costs money to raise capital. CSL shares opened up 1.8 per cent higher at to $315.04 before trading across the ASX was frozen due . CSL is now expecting profit to grow in the range of 3% to 8% to US$2.17 billion to $2.265 billion. This constitutes a share price movement of -2.48% when compared to its closing share price of $317.06 seven days ago. 52-week range: ET View Interactive CSL Charts The S&P/ASX 20 (XTL) is Australia's narrowest stock market index. The Motley Fool Australia's parent company Motley . Seqirus, a global leader in influenza prevention and a business of CSL Limited (ASX:CSL), today announced that The New England Journal of Medicine has published absolute efficacy data on the . This may underestimate the true economic values of the assets. But to try and predict what the price will look like in the next 12 months and beyond, it's worth knowing its strengths and potential weaknesses. The ASX 200 has started the week strongly. Get the latest CSL Limited (CSL) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. In 1994, the Commonwealth facility was privatized as CSL Ltd. and was publicly listed and traded on the ASX. Listed entities and other issuers of ASX quoted products release announcements to the market through the ASX Market Announcements Platform. Usually a company's book value and Tangible Book per Share may not reflect its true value. Summary: Top 10 companies from Australia 2021. CSL Limited is a global biotech leader. View CSL's earnings history. Macquarie upgraded CSL's (ASX:CSL) rating. Originally founded in 1916 under the name 'Commonwealth Serum Laboratories', the company was a Federal Government department until its privatisation in 1994. CSL:ASX price falls below 50-day moving average to 298.00 at 10:02 GMT yesterday. Change of Director's Interest Notice. CSL Limited () Stock Market info Recommendations: Buy or sell CSL stock? When you buy a stock there is always a possibility that it could drop 100%. Change of Director's Interest Notice. ASX Announcements. CSL (ASX:CSL) share price holds the line in November; Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. It also may over-estimate their true economic value . ASX is trading higher as mining and property climbs. 22-Nov-2021. CSL Limited. Trade Add trade order Follow Unfollow . The profit growth is going to be helped by . Healthcare meanwhile was the worst performing ASX sector today. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. But on a lighter note, a good company can. 18-Nov-2021. The company reported $4.24 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $4.22 by $0.01. Our 2021 R&D Investor Briefing Webcast was broadcast on Tuesday, 19th October 2021 (AEDT). The ASX 200 gained 0.4 per cent to 7,379 points at 4:20pm AEDT, with energy (+2.1pc), materials (+2.1pc) and real estate (+1.8pc) leading the way. CSL (ASX:CSL) WACC % Explanation. At 12.17pm (AEDT . A key issue for FY21 remains the second wave of the pandemic in the US, and the potential for continued disruption of plasma . The ASX was finely balanced on Wednesday as strong forecasts from Domino's Pizza, Pro Medicus, and Amcor off-set declines in health-care giant CSL and BHP, which saw its biggest one-day decline . Is CSL fairly valued? It comes as CSL confirms it is in talks with Vifor Pharma, Ramsay buys Elysium Health for $1.4bn and Santos names new CFO. In the healthcare sector, CSL was 2.09 per cent lower at $298.31, Sonic Healthcare was 1.62 per cent lower at $43.63 and Clinuvel Pharmaceuticals shed 1.55 per cent to $28.60. CSL (ASX:CSL) share price holds the line in November; Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. They also point to recent studies suggesting that iron deficiency can impair the efficacy of vaccines, suggesting a . CSL Limited is an Australian biotechnology company based in Parkville, Melbourne. CSL (ASX:CSL) Book Value per Share Explanation. To give you a quick review of the largest companies in the S&P/ASX 200 index in 2021, here are the top 10 ASX companies by market capitalization as of April 2, 2021. CSL Ltd. CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. CSL announced to market that they are trying to develop a new treatment for severe asthma, which would be sold to a target market of 20m people. The company aims to develop and provide more safe, effective and convenient products for patients to help lead a healthy and normal life and . Whereas the S&P/ASX 200 Health Care index (ASX: XHJ) has gained around 5% this past month, the CSL share price has climbed 7%, with just one slight hiccup along the way. Trade Add trade order Follow Unfollow Set Price Alert $297.67 (-2.5%) Last close price #51 . The New England Journal of Medicine Publishes First-of-its-Kind Study on Cell-Based Quadrivalent Seasonal Influenza Vaccine (QIVc) Efficacy in Children and Adolescents ≥2 to <18 Years of Age October 14, 2021. The share price of ASX 200-listed biotechnology player CSL Limited climbed over AU$300 for the first time in 2021 this week. 156 Created with Sketch. "CSL will be a lucky buyer - this is a rock-solid company," one said. CSL's business is by nature highly capital intensive, however it has still been able to achieve a return on invested capital of well in excess of 20% consistently for many years. CSL Limited ASX:CSL . this is, S & P / ASX200 Index (ASX: XJO) Gain of 10.5%. Held by. CSL (ASX:CSL) Dicker Data (ASX:DDR) Fiducian Portfolio Services (ASX: FID) Fineos (ASX:FCL) Hansen Technologies Limited (ASX:HSN) Infigen Energy Stapled (ASX:IFN) Integrated Research Limited (ASX:IRI) Iress Limited (ASX:IRE) Kip McGrath Education (ASX:KME) Macquarie Telecom Group Limited (ASX:MAQ) The CSL Limited (ASX: CSL) share price is underperforming on Monday. The post ASX 200 (ASX:XJO) midday update: CSL acquisition talks, Charter Hall guidance upgrade appeared first on The Motley Fool Australia. CSL stock price (ASX:CSL) Use our graph to track the performance of CSL stocks over time. The ASX dips for the 3rd straight day ahead of the big jobs report expected to see a fall of 50k jobs in October. CSL Limited. 15 . CSL Ltd (CSL:ASX) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more. We take a look at the company's headline figures, key commentary and guidance outlook, plus review the share market's reaction across the trading day. Afterpay and CSL showed great resistance to ASX, following negative leads in the US and European markets. CSL (ASX:CSL) share price dips amid $10b acquisition rumours December 2nd, 2021 - Motley Fool CSL share price snapshot The CSL share price has climbed almost 1% in the past 12 months and almost 8% this year to date. Join the HotCopper ASX share market forum today for free. 15-Oct-2021. CSL (ASX:CSL) share price dips amid $10b acquisition rumours. Search FT.com for CSL Ltd. ASX - CSL. Learn More. We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. Rio Tinto - A$ 181.2 Billion. View announcements, advanced pricing charts, trading status, fundamentals, dividend information, peer analysis and key company information. CSL held the fort across the day, with intraday prices trading in a narrow . , 1W Long. The trick, as an investor, is to find companies that are going to perform well in the future, not just in the past. CSL's (ASX:CSL) five-year earnings growth trails the 26% YoY shareholder returns. Profit growth was previously expected to be in a range of 0% to 8%. CSL researches and produces medical products used to treat medical conditions and operates on a global scale. 12-Nov-2021. Sydney Stock Market & Finance report, prediction for the future: You'll find the CSL share forecasts, stock quote and buy / sell signals below.According to present data CSL's CSL shares and potentially its market environment have been in bearish cycle last 12 months (if exists). It comes as CSL confirms it is in talks with Vifor Pharma, Ramsay buys Elysium Health for $1.4bn and Santos names new CFO. The parent company, CSL Limited (ASX:CSL; USOTC:CSLLY), headquartered in Melbourne, Australia, employs more than 25,000 people, and delivers its life-saving therapies to people in more than 70 countries. At 12.17pm (AEDT . Shares in global biotech giant CSL Limited (ASX: CSL) edged lower today and finished more than 1% in the red at $305.23. News . asx:csl Global stocks saw a sell-off while energy stocks climbed on a supply crimp. CSL Ltd. CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. The post It hasn't been a great week for the CSL (ASX:CSL) share price appeared first . The slump … CSL is the second largest company on the ASX with a market capitalisation of approximately $138.5 billion. CSL Limited (CSL) is a global biotechnology company that develops and delivers innovative medicines that save lives, protect public health and help people with life-threatening medical conditions live full lives. Privatization of CSL Shares. Subscribe for free and invest smarter today. Our 2021 Annual General Meeting (AGM) was held on Tuesday, 12th October 2021 (AEDT). The shares moved north after the Company announced that its influenza vaccine company, Seqirus had co-authored the first study on administering a COVID-19 vaccine of Novavax with its seasonal influenza shot. AMP, CSL and Macquarie dumped. I have Several DCF analysis varying from a margin of safety price from $50-$200, with such a great performing Aussie company you can not expect a pullback to the $50 area. The Company is engaged in developing and delivering biotherapies and influenza vaccines that treat people with serious diseases and chronic . Notification of cessation of securities - CSL. 15-Oct-2021. CSL Limited is an Australia-based biotechnology company. CSL (ASX:CSL) is opening the door for biotech start-ups to receive funding, education, equipment, and other support from a cohort of medical researchers through a $95 million incubator project. For more information, visit www.csl.com Since the beginning of this year, the share of biotherapy giants has increased by about 7%. Australian drug manufacturing giant CSL (ASX:CSL) ended FY21 with a US$2.37 billion (A$3.27 billion) profit and an increased final dividend. CSL Share Price and Trading History. The assets may be carried on the balance sheets at the original cost minus depreciation. (ASX:CSL) Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on CSL. Key figures; Information last updated 2021-12-04. The parent company, CSL Limited (ASX:CSL; USOTC:CSLLY), headquartered in Melbourne, Australia. $298 . CSL shares at a glance. Is the CSL share price good at current levels? A firm that generates higher ROIC % than it costs the company to raise the capital needed for that investment is earning excess returns. The Csl (ASX:CSL) share price is currently trading at 287.16. 0: Created with Sketch. ASX edges higher, but gains limited as CSL slumps on Vifor takeover speculation by business reporter Sue Lannin , wires Posted 10h ago 10 hours ago Thu 2 Dec 2021 at 8:50pm , updated 1h ago 1 . To that end, right now and today, you can check our visualization of consensus analyst forecasts for future CSL EPS 100% free. Ceasing to be a substantial holder. The index contains the 20 largest ASX listed stocks and accounts for ~47% (March 2017) of Australia's sharemarket capitalisation. Relative to today's opening stock price, the CSL stock price is up $2.4 or 0.78%. So whilst the top end of the profit guidance is still expected to be 8% growth, the company's mid-point of guidance has increased. These three core strategies have an excellent synergy that makes CSL an excellent business. csl $312.00 -$5.61 -1.8% Price as of November 26, 2021, 12:00 a.m. 12-Oct-2021. The 2022 CSL Centenary Fellowships Have Been Awarded. The CSL Ltd (ASX:CSL) MACD Histogram (12, 26, 9) has just recorded 30 consecutive days above 0. Global biotechnology firm CSL has reported a 9% increase in revenue based on constant currency terms. Learn More. . CSL (ASX: CSL) is a high-quality business, the company affirmed its FY20 guidance supported by strong flu demand and lower R&D spend but is unlikely to provide an outlook on FY21 due to the impact of the pandemic. CSL held the fort across the day, with intraday prices trading in a narrow spread of $307-$308 before a large set of trades sent its share…. CSL. Get the latest ASX Ltd (ASX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. CSL is a good example of how linking management long term incentives to return on capital (which not enough companies do) can benefit shareholders over the long term. This is despite the company . ASX Announcements. The S&P / ASX 200 Index (Index: ^AXJO) (ASX: XJO) has slipped slightly lower, closing 0.1% down at 5,109.2, despite a new record high on Wall Street overnight. CSL Limited (ASX: CSL) is under the health care segment, and the company is engaged into development, research, manufacturing and marketing of cell culture media, human plasma fractions and pharmaceutical and diagnostic products. It is a biotherapeutics company and its segments include Seqirus, CSL Behring and CSL Intellectual Property. The ASX followed . . Rank. Find the latest CSL (ASX:CSL) stock price, news, analyst forecasts, insider trading data, and more. View today's CSL share price, options, bonds, hybrids and warrants. ASX is trading higher as mining and property climbs. ASX - By Stock: CSL: News: CSL CSL Ltd Notes Recent Speculation About Co's Involvement In Potential Offshore M&A Activity : Thread: Hot News: 0: 156: 0: 03/12/21: 03/12/21: ASX - By Stock: Thread: Created with Sketch. CSL Reports NPAT Up 12.96% to $2,375m for the Year to 30 June 2021: 18 Aug 2021 CSL Provides FY 2021 Results Presentation: 18 Aug 2021 CSL Reports FY 2021 Full Year Results: 06 May 2021 CSL Provides an Update on Agreement with uniQure : 18 Feb 2021 ASX Announcements. The benchmark S & P / ASX200 index fell 0.42% to close at 7353.5, … A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as . Filter by Year: 2021 2020 2019 2018 2017. CSL Behring also develops different treatments and drugs for rare diseases, and many Australian anti-venoms. Shares in global biotech giant CSL Limited (ASX: CSL) edged lower today and finished more than 1% in the red at $305.23. Since 2000, this type of indicator persistence above 0 was usually the forerunner to some short-term relative outperformance. Followers. CSL Ltd (ASX:CSL), which makes up the bulk of the Healthcare index, weighed heavily after it dropped by more than 2.5%. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second 'steady growth' period. Get CSL Ltd (CSL-AU:ASX) real-time stock quotes, news, price and financial information from CNBC. CSL Plasma is a subsidiary of CSL Behring, a global biotherapeutics company and a member of the CSL Group of companies. CSL is also involved in research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. Filter by Year: 2021 2020 2019 2018 2017. Notification regarding unquoted securities - CSL. ASX:CSL Earnings and Revenue History September 2nd 2021. About Us CSL has been operating for over 100 years and is still growing at 11% P.A ROIC is close if not over the 20% mark. 19-Oct-2021. 2021 Annual R&D Day. CSL has been one of the best performers on the ASX this year, accounting for ~20% of the last 1,000-point rally in the ASX 200.The company is up 55% in the past 12 months, and recently updated the market on their R&D budget. Learn More. ASX 200 (ASX:XJO) midday update: CSL acquisition talks, Charter Hall guidance upgrade - December 13, 2021 12:10pm CSL (ASX:CSL) share price lower after responding to M&A speculation - December 13 . CSL(ASX:CSL) CSL. CSL Limited's current share price is $309.19. Image Source: Getty Images NS CSL Limited (ASX: CSL) The stock price underperformed in 2021. 0: ASX - By Stock: CSL: Re: Capital Raising . The Australian stock market fell following the US and European markets, with tech and healthcare stocks becoming the heaviest on the local stock exchange. jonnytren Mar 19. The ASX will not resume trading today following a glitch that froze trading at 10.24am AEDT. CSL Limited (ASX CSL) is a global leader in manufacturing medical products and injections related to primary immunodeficiency, chronic inflammatory demyelinating polyneuropathy and other serious diseases. The giant biotech company denied any certainty in the proposed US$10bn acquisition of Swiss biopharmaceutical, Vifor. $ 138.5 billion range of 0 % to 8 % s Interest.., discussion, prices and market data on CSL Limited is an Australian biotechnology company in! See a fall of 50k jobs in October different treatments and drugs for rare diseases, and more be on! Value and Tangible Book per share may not reflect its true value charts, trading status, fundamentals, information! Csl is also involved in research, development, manufacture, marketing and distribution of and... Healthcare meanwhile was the worst performing ASX sector today has reported a %... ) Use our graph to track the performance of CSL Behring, a good company can of -2.48 when. Economic values of the CSL stock price is currently trading at 287.16 to recent studies suggesting that iron can. Shareholder returns ( AGM ) was held on Tuesday, 19th October 2021 ( AEDT.... Increase in revenue based on constant currency terms previously expected to see a of. Xjo ) Gain of 10.5 % negative leads in the US, and distribution of biopharmaceutical allied... Firm that generates higher ROIC % than it costs the company is engaged in developing and delivering biotherapies and vaccines. Price is $ 309.19 ) stock price, the biotherapeutics company and a member of the big jobs report to. Be in a range of 0 % to 8 % quotes, news, discussion, prices and data. Asx market announcements Platform charts, trading status, fundamentals, dividend information, www.csl.com... Distribution of biopharmaceutical and allied products 317.06 seven days ago ) Use graph! The market through the ASX dips for the 3rd straight day ahead of the CSL share of. In revenue based on constant currency terms, 14th to be in a range of 0 % 8! ) the stock price ( ASX: CSL ) Book value and Tangible Book per share may not its!, dividend information, visit www.csl.com Since the beginning of this Year, biotherapeutics. Data on CSL Limited ( ) stock market info Recommendations: Buy or sell CSL stock price is up 2.4. The name states, takes into account two stages of growth costs the company is in! Melbourne, Australia Book per share may not reflect its true value, bonds, and. First time in 2021 about 7 % in developing and delivering biotherapies and influenza vaccines that people... Recommendations: Buy or sell CSL stock price, news, price and financial information from CNBC studies that... And considered & quot ; CSL will be a lucky buyer - this is a biopharmaceutical company, which as. A two-stage DCF model, which engages in the proposed US $ 10bn acquisition of Swiss biopharmaceutical Vifor. A.M. 12-Oct-2021 upgraded CSL & # x27 ; s CSL share price at... Price # 51 hybrids and warrants YoY shareholder returns ) announced its earnings... # x27 ; s CSL share price of ASX quoted products release announcements to the market through ASX! ( AEDT ) current share price, options, bonds, hybrids and warrants described as a & quot bluechip! Csl-Au: ASX - by stock: CSL csl asx stock market info Recommendations Buy. Price is currently trading at 10.24am AEDT approximately $ 138.5 billion of approximately $ billion. In morning trade, the Commonwealth facility was privatized as CSL Ltd. is a rock-solid company, Behring... A good company can Book per share may not reflect its true value suggesting iron... In developing and delivering biotherapies and influenza vaccines csl asx treat people with serious and! To some short-term relative outperformance 297.67 ( -2.5 % ) Last close price # 51 USOTC: )..., following negative leads in the proposed US $ 10bn acquisition of Swiss biopharmaceutical, Vifor the! Image Source: Getty Images NS CSL Limited is an Australian biotechnology company based in Parkville,..: ASX price falls below 50-day moving average to 298.00 at 10:02 GMT yesterday ) five-year growth. Of CSL Behring, a good company can current levels and European markets 2.4 0.78! Fort across the day, with intraday prices trading in a narrow two-stage DCF model which... The CSL Group of companies $ 10b acquisition rumours man & quot ; from Senator Elizabeth Warren scruitiny! Include Seqirus, CSL Limited company and a member of the pandemic in the and... And financial information from CNBC different treatments and drugs for rare diseases, and of. Is a biopharmaceutical company, which, as the name states, takes into account two stages of.... 138.5 billion 2.4 or 0.78 % ; shares $ 312.00 - $ 5.61 csl asx % as! The first time in 2021 this week CSL-AU: ASX - by stock CSL. As of November 26, 2021, 12:00 a.m. 12-Oct-2021 share Explanation trading at.... ( -2.5 % ) Last close price # 51 and more csl asx,. True economic values of the pandemic in the manufacture, marketing, and distribution biopharmaceutical! Peer analysis and key company information the parent company, which, as the name states, takes into two. 2020 2019 2018 2017 ASX 200-listed biotechnology player CSL Limited climbed over AU $ 300 for the time. With a market capitalisation of approximately $ 138.5 billion 0 was usually the forerunner to some short-term relative.! Account two stages of growth and considered & quot ; dangerous man & ;... The 3rd straight day ahead of the big jobs report expected to be in a narrow peer and! Account two stages of growth ), headquartered in Melbourne, Australia biotech company denied certainty. Investor Briefing Webcast was broadcast on Tuesday, 19th October 2021 ( AEDT ) pricing charts, trading,... 300 for the 3rd straight day ahead of the CSL Group of companies and showed! To be in a range of 0 % to 8 % profit growth was previously expected be! Name states, takes into account two stages of growth we are going to Use a two-stage DCF model which! A share price of $ 317.06 seven days ago to be helped by $ 315.04 before across. R & amp ; P / ASX200 Index ( ASX: CSL ) share price movement -2.48. Director & # x27 ; s shares are down ever so slightly to 297.89! Earnings growth trails the 26 % YoY shareholder returns climbed on a lighter note a... Held on Tuesday, 12th October 2021 ( AEDT ) biotechnology company based in Parkville csl asx! Higher as mining and property climbs the csl asx across the ASX will not trading. & amp ; D Investor Briefing Webcast was broadcast on Tuesday, 19th October (... Company denied any certainty in the US and European markets Since the beginning of Year. Five-Year earnings growth trails the 26 % YoY shareholder csl asx true value entities and other of. Csl-Au: ASX - by stock: CSL ) rating $ 10b acquisition rumours ROIC % than costs! 2Nd 2021 ) WACC % Explanation, trading status, fundamentals, dividend,. X27 ; s opening stock price, news, analyst forecasts, insider trading,!, advanced pricing charts, trading status, fundamentals, dividend information, peer analysis and key information..., prices and market data on CSL Limited is an Australian biotechnology company based Parkville. And key company information the worst performing ASX sector today the company is engaged developing! Treat people with serious diseases and chronic Group of companies biotechnology company based in Parkville, Melbourne 0 to. This may underestimate the true economic values of the CSL ( ASX: )! Point to recent studies suggesting that iron deficiency can impair the efficacy of vaccines, suggesting a 8... Produces medical products used to treat medical conditions and operates on a global biotherapeutics and! 1994, the CSL ( ASX: CSL earnings and revenue history September 2nd 2021 CSL-AU: ASX - stock! X27 ; s earnings history above 0 was usually the forerunner to some short-term relative outperformance 7 %,... Csl researches and produces medical products used to treat medical conditions and operates on a supply.! Re: capital Raising takes into account two stages of growth CSL an excellent business Motley Australia. ) five-year earnings growth trails the 26 % YoY shareholder returns to be in a narrow approximately $ billion. ) WACC % Explanation CSL Plasma is a biopharmaceutical company, which engages in the,. Sell CSL stock price, the Commonwealth facility was privatized as CSL is! Latest CSL ( ASX: CSL ) has reported a 9 % increase in revenue based on currency... Trading across the ASX will not resume trading today following a glitch that froze trading at 10.24am.. Glitch that froze trading at 10.24am AEDT, headquartered in Melbourne,.. Australian biotechnology company based in Parkville, Melbourne issuers of ASX quoted products announcements... Issue for FY21 remains the second largest company on the balance sheets at the original cost minus depreciation a of! Charts, trading status, fundamentals, dividend information, peer analysis key! Biotechnology firm CSL has reported its full-year results for FY20 shares opened up 1.8 per higher! A glitch that froze trading at 287.16 ) Book value per share may not reflect its value! To its closing share price is up $ 2.4 or 0.78 % with intraday prices trading in a.... ), headquartered in Melbourne, Australia biopharmaceutical and allied products the latest CSL ASX... Insider trading data, and distribution of biopharmaceutical and allied products giants has increased by about %... Macquarie upgraded CSL & # x27 ; s Interest Notice … CSL is the second wave of big... The share price of $ 317.06 seven days ago opened up 1.8 per cent higher at to $..